Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Peter Gale

Showing results (101-110 of 557) with videos related to

Pageof 56
Sort By:
Acta Haematologica|August 14, 2020
G-CSF and GM-CSF Are Different. Which One Is Better for COVID-19?Hillard M Lazarus, Robert Peter Gale
Bone Marrow Transplantation|July 14, 2022
Statistical challenges in haematopoietic cell transplantationRobert Peter Gale, Mei-Jie Zhang
Bone Marrow Transplantation|November 22, 2023
Is myelo-ablative pretransplant conditioning really myelo-ablative: Implications for radiation and nuclear accidents?Robert Peter Gale, Hillard M Lazarus
Bone Marrow Transplantation|July 3, 2020
Liaisons Dangereuses? new drugs, physicians and the drug industryRobert Peter Gale, Hillard M Lazarus
Journal of Cancer Research and Clinical Oncology|January 31, 2018
Patients' and hematologists' concerns regarding tyrosine kinase-inhibitor therapy in chronic myeloid leukemiaQian Jiang, Lu Yu, Robert Peter Gale
Bone Marrow Transplantation|April 10, 2020
Clara Bloomfield MD: Queen of AML. Dare to cross her at your risk (May 15, 1942 to March 1, 2020)Robert Peter Gale, Rüdiger Hehlmann, Andreas Hochhaus
Mediterranean Journal of Hematology and Infectious Diseases|May 19, 2021
Cost-Effectiveness of Post-Autotransplant Lenalidomide in Persons with Multiple MyelomaMonia Marchetti, Robert Peter Gale, Giovanni Barosi
Haematologica|May 2, 2019
Precision tyrosine kinase inhibitor dosing in chronic myeloid leukemia?Giuseppe Saglio, Carmen Fava, Robert Peter Gale
Acta Haematologica|July 24, 2025
Beyond CAR-T: The Rise of CAR-NK/T Cells for Haematological CancerMohammadamin Noorafrooz, Robert Peter Gale, Mohadese Dashtkoohi
Acta Haematologica|August 26, 2015
Isochromosome X in Myelodysplastic SyndromeKhalid Halahleh, Robert Peter Gale, Arnon Nagler
Pageof 56

Showing results (101-110 of 557) with videos related to

Sort By:
Pageof 56
Acta Haematologica|August 14, 2020
G-CSF and GM-CSF Are Different. Which One Is Better for COVID-19?Hillard M Lazarus, Robert Peter Gale
Bone Marrow Transplantation|July 14, 2022
Statistical challenges in haematopoietic cell transplantationRobert Peter Gale, Mei-Jie Zhang
Bone Marrow Transplantation|November 22, 2023
Is myelo-ablative pretransplant conditioning really myelo-ablative: Implications for radiation and nuclear accidents?Robert Peter Gale, Hillard M Lazarus
Bone Marrow Transplantation|July 3, 2020
Liaisons Dangereuses? new drugs, physicians and the drug industryRobert Peter Gale, Hillard M Lazarus
Journal of Cancer Research and Clinical Oncology|January 31, 2018
Patients' and hematologists' concerns regarding tyrosine kinase-inhibitor therapy in chronic myeloid leukemiaQian Jiang, Lu Yu, Robert Peter Gale
Bone Marrow Transplantation|April 10, 2020
Clara Bloomfield MD: Queen of AML. Dare to cross her at your risk (May 15, 1942 to March 1, 2020)Robert Peter Gale, Rüdiger Hehlmann, Andreas Hochhaus
Mediterranean Journal of Hematology and Infectious Diseases|May 19, 2021
Cost-Effectiveness of Post-Autotransplant Lenalidomide in Persons with Multiple MyelomaMonia Marchetti, Robert Peter Gale, Giovanni Barosi
Haematologica|May 2, 2019
Precision tyrosine kinase inhibitor dosing in chronic myeloid leukemia?Giuseppe Saglio, Carmen Fava, Robert Peter Gale
Acta Haematologica|July 24, 2025
Beyond CAR-T: The Rise of CAR-NK/T Cells for Haematological CancerMohammadamin Noorafrooz, Robert Peter Gale, Mohadese Dashtkoohi
Acta Haematologica|August 26, 2015
Isochromosome X in Myelodysplastic SyndromeKhalid Halahleh, Robert Peter Gale, Arnon Nagler
Pageof 56